JI Lim, AE Fung, M Wieland, D Hung… - Ophthalmology, 2011 - Elsevier Patients received a single intravitreal injection of IBI-20089 using a sequential dose escalation schedule. Each cohort consisted of 5 patients who received the intravitreal injection of the sustained liquid drug delivery system containing either 6.9 mg (25 μl) triamcinolone acetonide (TA; ... Related articles - All 3 versions
V Manjunath… - Retinal Cases and Brief Reports, 2011 - journals.lww.com This work was supported in part by a Research to Prevent Blindness Challenge grant to the New England Eye Center, Tufts University School of Medicine, National Institutes of Health contracts RO1-EY11289-23, R01-EY13178-07, Air Force Office of Scientific Research ... Related articles - All 3 versions
YS Wang, X Li, HY Wang, ZF Zhang… - Chinese medical …, 2011 - ncbi.nlm.nih.gov BACKGROUND: Diabetic macular edema (DME) is a common manifestation of diabetic retinopathy (DR) that forms the main cause of central visual impairment. This study aimed to compare the efficacy and safety of a single intravitreal injection of bevacizumab alone versus ...
R Ehrlich, TA Ciulla, A Moss… - Graefe's Archive for Clinical and …, 2011 - Springer Dear Editor, We thank the authors for their interest in our study. We agree that combined treatment with triamcinolone could reduce the number of recurrent treatments with bevacizumab. However, the combination treatment did not seem to change the visual acuity outcome ... All 3 versions
MM Soliman, DM Ashcroft, KD Watson… - …, 2011 - Br Soc Rheumatology Methods: The analysis involved 550 RA patients registered with the BSRBR, who were starting RTX and were followed up for at least 6 months. Change in Disease Activity Score (DAS28) and European League Against Rheumatism (EULAR) response were used to assess the ...
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
